Product Pathways - NF-kB Signaling
IFI16 Antibody #8079
|8079S||100 µl (10 western blots)||---||In Stock||---|
|8079||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|W||1:1000||Human||Endogenous||85, 95, 98||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Specificity / Sensitivity
IFI16 Antibody recognizes endogenous levels of total IFI16 protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro399 of human IFI16 protein. Antibodies are purified by protein A and peptide affinity chromatography.
IFI16 belongs to the PYHIN family, which consists of four members in humans (Aim2, IFIX, MNDA, and IFI16) and at least thirteen members in mice (1). The closest homolog of IFI16 in mice is p204. The PYHIN family is characterized by the presence of one or two HIN-200 domains that bind double stranded DNA and a PYRIN domain that mediates interactions among family members, as well as the inflammasome-forming ASC protein (1). IFI16 also has a nuclear localization signal, but has been observed to bind DNA in both the cytoplasm and nucleus (2,3). There are three isoforms of IFI16 produced by alternative splicing (4). IFI16 is constitutively expressed by some cells, such as lymphocytes, and highly inducible in many others by interferons (5). IFI16 has been shown to directly interact with p53 and to play a role in cellular senescence by modulating p53 activity (6). Recently, IFI16 was shown to directly sense intracellular viral DNA, leading to recruitment of STING and activation of IRF-3 and NF-κB (2). Investigators have observed increased levels of IFI16 and anti-IFI16 autoantibodies in patients with systemic lupus erythematosus (7-9).
- Keating, S.E. et al. (2011) Trends Immunol 32, 574-81.
- Unterholzner, L. et al. (2010) Nat Immunol 11, 997-1004.
- Kerur, N. et al. (2011) Cell Host Microbe 9, 363-75.
- Johnstone, R.W. et al. (1998) Biochemistry 37, 11924-31.
- Trapani, J.A. et al. (1992) Immunogenetics 36, 369-76.
- Johnstone, R.W. et al. (2000) Oncogene 19, 6033-42.
- Choubey, D. and Panchanathan, R. (2008) Immunol Lett 119, 32-41.
- Mondini, M. et al. (2006) Arthritis Rheum 54, 3939-44.
- Seelig, H.P. et al. (1994) Arthritis Rheum 37, 1672-83.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.